The linear-quadratic formula and progress in fractionated radiotherapy
Tóm tắt
Clinical gains have been reported from the use of nonstandard fractionation schedules planned with a radiobiological basis. Hyperfractionation provides the leading example, as described below, with accelerated fractionation being developed more recently. Although examples of almost every kind of fractionated schedule can be found in the literature over the past 90 years, it is only within the last decade that the biological factors concerning overall time and delayed proliferation after irradiation, and the effect of dose per fraction, have been understood. Both these factors operate differently on late- and early-reacting tissues, because cell proliferation in late-reacting tissues is slow or absent, but early reacting tissues and tumours depend upon cells that proliferate rapidly. This basic knowledge is still diffusing through the radiotherapy community and I hope this review will help the diffusion process. The biological factors concerning fractionation seem to apply to the majority of tissues and tumours, so that new schedules can be planned that are effective in practice.
Attempts to deal with hypoxic cells in tumours or to use high-linear-energy-transfer (LET) radiation have been less generally successful, probably because in those strategies we need to identify subpopulations that are smaller. Tumours that are resistant to conventional radiotherapy because they contain hypoxic cells and do not reoxygenate cannot be identifed yet.
Từ khóa
Tài liệu tham khảo
BACLESSE F., Progress in Radiation Therapy (Grune & Stratton, 128
BARENDSEN G. W., 1982, Physics, 8, 1981
COUTARD H., 1932, American Journal of Roentgenology, 28, 313
DENEKAMP J., 1976, Cell and Tissue Kinetics, 9, 19
FISHER D. R., 1986, British Journal of Cancer, 53, 298
FOWLER J. F., 1984, The Biological Basis of Radiotherapy, ed. by G. G. Steel, 181
3rd International Symposium on Time Dose
FOWLER, J. F., WHITSED, C. A. & HALFYARD, A., 1987. Is there a loss of repair in multifraction irradiation of mouse Iung? Gray Laboratory Annual Report, p.50 (Abstract).
HEGAZY M. A., 1973, Cell and Tissue Kinetics, 6, 587
HORIOT J. C, 1988, Physics, 15, 178
MACIEJEWSKI B., 1983, Physics, 9, 321
MALAISE E. P., 1988, Proceedings of the 3rd International Symposium on Time Dose and Fractionation
MEYER J. S., 1981, Pathology Annual, 16, (Part 2), 53
MITCHELL J. S., Studies in Radiotherapeutics
OVERGAARD M., 1985, Physics, 11, 1225
Suppl. VII, 320
PARSONS J. T., 1980, Physics, 6, 1645
PARSONS J. T., 1988, Physics, 14, 649
PIPARD G., 7th Annual Meeting ofESTRO, Den Haag, 233
PETERS L. J., Megavoltage Radiotherapy 1937-1987, British Journal of Radiology, Suppl. 22, 9
SAUNDERS M., Frontiers of Radiation Therapy and Oncology, 22, 99
SHELINE G. E., 1980, Physics, 6, 1215
STEEL, G. G., 1977. Growth Kinetics of Tumours (Clarendon Press, Oxford), pp.191, 202.
STEWART F. A., 1980, Cell and Tissue Kinetics, 13, 75
SUIT H. D., 1988, Proceedings of the 3rd International Symposium on Time Dose and Fractionation
THAMES, H. D. & HENDRY, J. H., 1987. Fractionation in Radiotherapy (Taylor & Francis, London), pp.297.
THAMES M. D., 1983, Physics, 9, 127
THAMES H. D., 1982, Physics, 8, 219
THOMAS F., 1988, Physics, 15, 1097
TRAVIS E. L., 1983, Physics, 9, 691
TRAVIS E. L., 1987, Physics, 13, 283
TURESSON I., 1984, Physics, 10, 593
VAN RONGEN E ., 1988, Physics, 15, 1161
WANG C. C, 1988, Physics, 14, 1143
WEST C, 1988, Proceedings of the 3rd International Symposium on Time Dose and Fractionation
WILLIAMS M. V., 1985, Physics, 11, 87
WITHERS H. R., Progress in Radio-Oncology IV, ed. by K. H. Karcher, H. D. Kogelnik, B. Stadler & T. Szepesi (International Club for Radio-Oncology, 181
WITHERS H. R., 1976, Physics, 4, 595
WITHERS H. R., Progress in Radio-Oncology, 287